Nitrosamines RA evaluation deadline extended due to coronavirus spreading
European Medicines Regulatory Network agreed to proceed with the extension of the Step 1 (risk evaluation) deadline to October 1st, 2020, due to Covid-19 spreading.
Tag: EMA
Why MD Cybersecurity is so important
Why MD Cybersecurity is so important by Danilo Maruccia, Executive Consultant & […]
EMA 2025 Regulatory Strategy
European Medicines Agency (EMA), has published its draft of ‘Regulatory Science to 2025’ […]